Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

(2016) S. Wergeland et al.   EUROPEAN JOURNAL OF NEUROLOGY

The beneficial effects of vitamin D3 on reducing antibody titers against Epstein–Barr virus in multiple sclerosis patients

(2015) Adeleh Najafipoor et al.   CELLULAR IMMUNOLOGY

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis

(2015) Egil Røsjø et al.   JOURNAL OF NEUROLOGY

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

(2015) Lazaros Belbasis et al.   LANCET NEUROLOGY

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT

(2015) Kassandra L. Munger et al.   NEUROLOGY

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

(2015) Kathryn C. Fitzgerald et al.   JAMA Neurology

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

(2014) Silje Kvistad et al.   Multiple Sclerosis Journal

Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis

(2014) Shurong Duan et al.   NEUROSCIENCE LETTERS

Age-Specific Prevalence of Epstein–Barr Virus Infection Among Individuals Aged 6–19 Years in the United States and Factors Affecting Its Acquisition

(2013) Henry H. Balfour et al.   JOURNAL OF INFECTIOUS DISEASES

Vitamin d deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study

(2013) Samar Ojaimi et al.   Journal of Translational Medicine

Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort

(2013) Caren Ramien et al.   Multiple Sclerosis Journal

Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

(2013) Giulio Disanto et al.   Multiple Sclerosis Journal

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis

(2013) E Sundqvist et al.   Multiple Sclerosis Journal

Understanding the joint effects of EBV and vitamin D in MS

(2013) Kassandra Munger et al.   Multiple Sclerosis Journal

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples

(2013) Jonatan Salzer et al.   Multiple Sclerosis Journal

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis

(2013) Eleanor James et al.   Multiple Sclerosis Journal

Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis

(2013) Yahya H. Almohmeed et al.   PLoS One

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

(2012) Margitta T Kampman et al.   Multiple Sclerosis Journal

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

(2012) Benjamin Terrier et al.   ARTHRITIS RESEARCH & THERAPY

Epstein-Barr virus and multiple sclerosis: interaction with HLA

(2011) E Sundqvist et al.   GENES AND IMMUNITY

Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial

(2011) Linn H. Steffensen et al.   JOURNAL OF NEUROLOGY

EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy

(2011) Manuel Comabella et al.   Multiple Sclerosis Journal

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis

(2011) Ellen M Mowry et al.   Multiple Sclerosis Journal

Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

(2011) Stephanie Knippenberg et al.   Multiple Sclerosis Journal

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

(2009) Jan D. Lünemann et al.   ANNALS OF NEUROLOGY

Antibodies to specific EBNA-1 domains and HLA DRB1⁎1501 interact as risk factors for multiple sclerosis☆

(2009) Peter Sundström et al.   JOURNAL OF NEUROIMMUNOLOGY

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI

(2009) R. A. Farrell et al.   NEUROLOGY

Regulation of vitamin D homeostasis: implications for the immune system

(2008) Evelyne Van Etten et al.   NUTRITION REVIEWS

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis

(2007) Trygve Holmøy   MEDICAL HYPOTHESES